.png){kind=icon}
.png){kind=icon}
Return
Current developments in device-based rhythm therapy
.png){kind=icon}
PRE
AI
DOI：10.1007/s00398-026-00764-y.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Device-based rhythm therapy has fundamentally evolved in recent years. Conventional implants consisting of a generator and transvenous leads have largely been optimized and are now characterized by miniaturization, extended battery life and magnetic resonance imaging (MRI) compatibility. To circumvent specific lead-related complications, novel technologies, such as leadless pacemakers and subcutaneous implantable cardioverter defibrillators (ICD) are gaining prominence. In the realm of physiological pacing methods conduction system pacing (CSP), particularly left bundle branch pacing (LBB pacing), is increasingly complementing traditional cardiac resynchronization therapy. Furthermore, innovative approaches such as artificial intelligence (AI)-assisted diagnostics, wearables and biological pacemakers offer promising prospects but require careful clinical evaluation.
Keywords:
Herzschrittmacher
Implantierbarer Kardioverter-Defibrillator
Kardiale Resynchronisationstherapie
K & uuml
nstliche Intelligenz
Tragbare elektronische Ger & auml
te
Pacemaker
Implantable cardioverter defibrillator
Cardiac resynchronization therapy
Artificial intelligence
Wearable electronic devices
Journal
Z
IF:
0.1
Papers:
38
Citations:
28